[1]
Burlaka, B.S. 2021. Optimization of the composition of a nasal medicine with interleukin-1 antagonist β. Farmatsevtychnyi zhurnal. 1 (Feb. 2021), 43-49. DOI:https://doi.org/10.32352/0367-3057.1.21.05.